Sino Biopharmaceutical Dividende
Zukünftiges Wachstum Kriterienprüfungen 0/6
Sino Biopharmaceutical is a dividend paying company with a current yield of 1.67%.
Wichtige Informationen
1.7%
Dividendenausschüttung
0.9%
Rückkaufsrendite
| Gesamte Aktionärsrendite | 2.6% |
| Zukünftige Dividendenrendite | 2.6% |
| Wachstum der Dividende | 14.1% |
| Nächster Dividendenzahlungstermin | n/a |
| Ex-Dividendendatum | n/a |
| Dividende pro Aktie | HK$0.060 |
| Ausschüttungsquote | 47% |
Aktuelle Dividendenentwicklung
Recent updates
After Leaping 27% Sino Biopharmaceutical Limited (HKG:1177) Shares Are Not Flying Under The Radar
Oct 02
Here's Why Sino Biopharmaceutical (HKG:1177) Can Manage Its Debt Responsibly
Sep 02Are Investors Undervaluing Sino Biopharmaceutical Limited (HKG:1177) By 48%?
Jul 12Here's Why Sino Biopharmaceutical (HKG:1177) Can Manage Its Debt Responsibly
May 21Sino Biopharmaceutical Limited's (HKG:1177) 27% Cheaper Price Remains In Tune With Earnings
Apr 21What Does The Future Hold For Sino Biopharmaceutical Limited (HKG:1177)? These Analysts Have Been Cutting Their Estimates
Apr 03Sino Biopharmaceutical Limited's (HKG:1177) Intrinsic Value Is Potentially 34% Above Its Share Price
Mar 20Sino Biopharmaceutical Limited's (HKG:1177) Shares May Have Run Too Fast Too Soon
Dec 18Does Sino Biopharmaceutical (HKG:1177) Have A Healthy Balance Sheet?
Dec 02Sino Biopharmaceutical Limited (HKG:1177) Shares Could Be 41% Below Their Intrinsic Value Estimate
Nov 17We Think Sino Biopharmaceutical (HKG:1177) Can Manage Its Debt With Ease
Aug 30Is There An Opportunity With Sino Biopharmaceutical Limited's (HKG:1177) 50% Undervaluation?
May 26Sino Biopharmaceutical (HKG:1177) Has A Rock Solid Balance Sheet
Apr 20Is Sino Biopharmaceutical Limited (HKG:1177) Trading At A 38% Discount?
Feb 09Is There An Opportunity With Sino Biopharmaceutical Limited's (HKG:1177) 41% Undervaluation?
Nov 11Sino Biopharmaceutical (HKG:1177) Seems To Use Debt Quite Sensibly
Oct 24Is There An Opportunity With Sino Biopharmaceutical Limited's (HKG:1177) 46% Undervaluation?
Jul 08Is Sino Biopharmaceutical (HKG:1177) Using Too Much Debt?
Apr 28Stabilität und Wachstum des Zahlungsverkehrs
Rufe Dividendendaten ab
Stabile Dividende: 1177 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are stable.
Wachsende Dividende: 1177 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are increasing.
Dividendenrendite im Vergleich zum Markt
| Sino Biopharmaceutical Dividendenrendite im Vergleich zum Markt |
|---|
| Segment | Dividendenrendite |
|---|---|
| Unternehmen (1177) | 1.7% |
| Untere 25 % des Marktes (HK) | 3.2% |
| Markt Top 25 % (HK) | 7.9% |
| Branchendurchschnitt (Pharmaceuticals) | 3.7% |
| Analystenprognose (1177) (bis zu 3 Jahre) | 2.6% |
Bemerkenswerte Dividende: 1177's dividend (1.67%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (3.25%).
Hohe Dividende: 1177's dividend (1.67%) is low compared to the top 25% of dividend payers in the Hong Kong market (7.92%).
Gewinnausschüttung an die Aktionäre
Abdeckung der Erträge: 1177 is not paying a notable dividend for the Hong Kong market.
Barausschüttung an die Aktionäre
Cashflow-Deckung: 1177 is not paying a notable dividend for the Hong Kong market.